首页> 美国卫生研究院文献>BMC Cancer >Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

【2h】

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

机译：在从头转移性鼻咽癌患者中确定局部治疗原发性肿瘤的最佳人选：一项基于爱泼斯坦-巴尔病毒DNA水平和姑息性化疗对肿瘤反应的回顾性队列研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTo evaluate the clinical outcome in patients with de novo metastatic nasopharyngeal carcinoma (NPC) treated or not treated with locoregional radiotherapy (LRRT) based on plasma Epstein–Barr virus (EBV) DNA level and tumor response after palliative chemotherapy (PCT).

机译：背景基于血浆爱泼斯坦-巴尔病毒（EBV）DNA水平和姑息化疗后（PCT）的肿瘤反应，评估局部放疗（LRRT）治疗或未治疗的从头转移性鼻咽癌（NPC）患者的临床结局。

著录项

期刊名称 BMC Cancer
作者
Xue-Song Sun; Li-Ting Liu; Sai-Lan Liu; Shan-Shan Guo; Yue-Feng Wen; Hao-Jun Xie; Qing-Nan Tang; Yu-Jing Liang; Xiao-Yun Li; Jin-Jie Yan; Jun Ma; Qiu-Yan Chen; Lin-Quan Tang; Hai-Qiang Mai;
展开▼
作者单位

展开▼
年(卷),期 2019(19),-1
年度 2019
页码 92
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Metastatic nasopharyngeal carcinoma Epstein–Barr virus DNA Tumor response Local treatment Radiotherapy Survival;

机译：转移性鼻咽癌;爱泼斯坦-巴尔病毒DNA;肿瘤反应;局部治疗;放疗;生存;

相似文献

外文文献
中文文献
专利

1. Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [18F]‐fluorodeoxyglucose positron emission tomography [J] . Hao‐Jun Xie, Yi‐Fei Yu, Xue‐Song Sun, Cancer Medicine . 2020,第23期

机译：基于预处理Epstein-BART病毒DNA和[18F] - 氟二氧葡萄糖正电子发射断层扫描术的II-IVA鼻咽癌阶段IVA鼻咽癌癌癌癌中的最佳候选
2. Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy. [J] . An X, Wang FH, Ding PR, Cancer: A Journal of the American Cancer Society . 2011,第16期

机译：血浆爱泼斯坦-巴尔病毒DNA水平强烈预测了姑息化疗治疗的转移性/复发性鼻咽癌的存活率。
3. Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy [J] . Xin An MD, Feng-Hua Wang MD PhD, Pei-Rong Ding MD PhD, Cancer . 2011,第16期

机译：血浆爱泼斯坦-巴尔病毒DNA水平强烈预测转移性/复发性鼻咽癌姑息性化疗的存活率
4. Photoelectrochemical Measurement of Epstein-Barr Virus DNA in Peripheral Blood Serum of Nasopharyngeal Carcinoma Patients [C] . Kusmardi Kusmardi, Aryo Tedjo, Yurnadi Hanafi Midoen, International Symposium of Biomedical Engineering . 2019

机译：鼻咽癌外周血血清Epstein-Barr病毒DNA的光电化学测量
5. Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [O] . Hao‐Jun Xie, Yi‐Fei Yu, Xue‐Song Sun, 2020

机译：基于预处理Epstein-Barr病毒DNA和Nodal最大标准摄取值鉴定II-IVA鼻咽癌中的诱导化疗的最佳候选者。
6. Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy [O] . Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu, 2019

机译：鉴定DE Novo转移性鼻咽癌患者局部肿瘤的最佳候选者：基于Epstein-Barr病毒DNA水平的回顾性队列研究和肿瘤反应姑息化疗

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅